相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。From COVID-19 to clot: the involvement of the complement system
Mohamed A. Hendaus et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
Repurposing of chloroquine and some clinically approved antiviral drugs as effective therapeutics to prevent cellular entry and replication of coronavirus
Akinwunmi O. Adeoye et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin
Anwarul Hasan et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Potential anti-viral activity of approved repurposed drug against main protease of SARS-CoV-2: anin silicobased approach
Saurov Mahanta et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2
Satyajit Beura et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations
I. Aanouz et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment
Subramanian Boopathi et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2
Rajib Islam et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Truncated human angiotensin converting enzyme 2; a potential inhibitor of SARS-CoV-2 spike glycoprotein and potent COVID-19 therapeutic agent
Abdul Basit et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication
Naun Lobo-Galo et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19
Nisha Muralidharan et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Effect of biosolids characteristics on retention and release behavior of azithromycin and ciprofloxacin
Caleb Gravesen et al.
ENVIRONMENTAL RESEARCH (2020)
Comparative effectiveness of tamoxifen, toremifene, letrozole, anastrozole, and exemestane on lipid profiles in breast cancer patients A network meta-analysis
Tao He et al.
MEDICINE (2020)
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
Emmie de Wit et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression
Lan Zhu et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Ivermectin and COVID-19: Keeping Rigor in Times of Urgency
Carlos Chaccour et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2020)
Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia
Shengyu Zhang et al.
CLINICAL DRUG INVESTIGATION (2020)
SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus
Michele Costanzo et al.
CURRENT MEDICINAL CHEMISTRY (2020)
Neurological disorder and psychosocial aspects of cerebral malaria: what is new on its pathogenesis and complications? A minireview
Arif Jamal Siddiqui et al.
FOLIA PARASITOLOGICA (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
COVID-19 Drug Discovery Using Intensive Approaches
Ayumu Asai et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Remdesivir for patients with severe COVID-19
M. Augustin et al.
INTERNIST (2020)
Impact of the first-line treatment shift from dihydroartemisinin/piperaquine to artesunate/mefloquine on Plasmodium vivax drug susceptibility in Cambodia
Camille Roesch et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Favipiravir, an antiviral for COVID-19?
Eric A. Coomes et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Elevated interleukin-6 and severe COVID-19: A meta-analysis
Muhammad Aziz et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Treatment options for COVID-19: The reality and challenges
Shio-Shin Jean et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2020)
Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence
Yu-chen Cao et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Chloroquine and hydroxychloroquine in covid-19
Robin E. Ferner et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Remdesivir in covid-19
Robin E. Ferner et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Potential therapeutic agents against COVID-19: What we know so far
Chih-Chia Lu et al.
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2020)
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
Yadi Zhou et al.
CELL DISCOVERY (2020)
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Jia Liu et al.
CELL DISCOVERY (2020)
The COVID-19 vaccine development landscape
Tung Thanh Le et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
Qingxian Cai et al.
ENGINEERING (2020)
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
Joshua Geleris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Compassionate Use of Remdesivir for Patients with Severe Covid-19
J. Grein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Leon Caly et al.
ANTIVIRAL RESEARCH (2020)
Immune responses in liver and spleen against Plasmodium yoelii pre-erythrocytic stages in Swiss mice model
Arif Jamal Siddiqui et al.
JOURNAL OF ADVANCED RESEARCH (2020)
Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection A Randomized Clinical Trial
Mayla Gabriela Silva Borba et al.
JAMA NETWORK OPEN (2020)
Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents
Ahmed Yaqinuddin et al.
MEDICAL HYPOTHESES (2020)
In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect
Julien Andreani et al.
MICROBIAL PATHOGENESIS (2020)
Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency
Thamina Acter et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2020)
Treatment with Hydroxychloroquine vs Hydroxychloroquine plus Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trial
Jose Meneses Calderon et al.
TRIALS (2020)
Systematic review of registered trials of Hydroxychloroquine prophylaxis for COVID-19 healthcare workers at the first third of 2020
Anne-Lise Bienvenu et al.
ONE HEALTH (2020)
Mobilizing the research ecosystem for scientific advances towards positive impact in the context of the COVID-19 Pandemic
Hasan Mandal
TURKISH JOURNAL OF MEDICAL SCIENCES (2020)
Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance
R. Choudhary et al.
NEW MICROBES AND NEW INFECTIONS (2020)
A retrospective cohort study of methylprednisolone therapy in severe patients with COVID-19 pneumonia
Yin Wang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Antiviral treatment of COVID-19
Serap Simsek Yavuz et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2020)
Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir
Egor P. Tchesnokov et al.
VIRUSES-BASEL (2019)
Strategies to Control Human Lymphatic Filarial Infection: Tweaking Host's Immune System
Puvvada Kalpana Murthy
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2019)
Clinical efficacy of umifenovir in influenza and ARVI (study ARBITR)
N. Yu Pshenichnaya et al.
TERAPEVTICHESKII ARKHIV (2019)
Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
Min-Han Lin et al.
ANTIVIRAL RESEARCH (2018)
Favipiravir as a potential countermeasure against neglected and emerging RNA viruses
Leen Delang et al.
ANTIVIRAL RESEARCH (2018)
MERS-CoV: Understanding the Latest Human Coronavirus Threat
Aasiyah Chafekar et al.
VIRUSES-BASEL (2018)
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
Maria L. Agostini et al.
MBIO (2018)
Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
Yousuke Furuta et al.
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2017)
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Timothy P. Sheahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Synthesis of primaquine glyco-conjugates as potential tissue schizontocidal antimalarial agents
Chandra S. Azad et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2017)
Repetitive live sporozoites inoculation under arteether chemoprophylaxis confers protection against subsequent sporozoite challenge in rodent malaria model
Jyoti Bhardwaj et al.
ACTA TROPICA (2016)
Coronaviruses - drug discovery and therapeutic options
Alimuddin Zumla et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import (vol 6, 23138, 2016)
Veronika Gotz et al.
SCIENTIFIC REPORTS (2016)
Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like Disease
Jasper F. W. Chan et al.
CLINICAL MICROBIOLOGY REVIEWS (2015)
Cloning, expression and functional characterization of heme detoxification protein (HDP) from the rodent malaria parasite Plasmodium vinckei
Awakash Soni et al.
GENE (2015)
Assessment of real-time method to detect liver parasite burden under different experimental conditions in mice infected with Plasmodium yoelii sporozoites
Arif Jamal Siddiqui et al.
MICROBIAL PATHOGENESIS (2015)
Host immune response is severely compromised during lethal Plasmodium vinckei infection
Jyoti Bhardwaj et al.
PARASITOLOGY RESEARCH (2015)
Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond
Guangwen Lu et al.
TRENDS IN MICROBIOLOGY (2015)
Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture
Adriaan H. de Wilde et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection
Julie Dyall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays
Brit J. Hart et al.
JOURNAL OF GENERAL VIROLOGY (2014)
Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques
Darryl Falzarano et al.
NATURE MEDICINE (2013)
Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug
Eloise Mastrangelo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium
Amy C. Sims et al.
VIRUS RESEARCH (2008)
分享论文
